Showing results (411-420 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 25, 2008
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemiaOlatoyosi M Odenike, Richard A Larson, Devika Gajria, et al.Investigational New Drugs|December 16, 1998
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11]J D Jonkman-de Vries, H Rosing, H Talsma, et al.Investigational New Drugs|December 16, 1998
Phase I and pharmacokinetic study of intraperitoneal topotecanS C Plaxe, R D Christen, J O'Quigley, et al.Investigational New Drugs|December 16, 1998
Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trialR S Witte, J Manola, P A Burch, et al.Investigational New Drugs|January 1, 1996
Topoisomerase I interactive drugs in children with cancerC F Stewart, W C Zamboni, W R Crom, et al.Investigational New Drugs|January 1, 1996
Pharmacologic strategies for the treatment of meningeal malignancyS M Blaney, D G PoplackInvestigational New Drugs|January 1, 1996
Purity determinations in the bulk drug of the novel indoloquinone antitumor agent EO9J D Jonkman-de Vries, J J Kettenes-van den Bosch, R E Henrar, et al.Investigational New Drugs|January 1, 1996
Phase II study of Mitonafide in advanced and relapsed colorectal cancerA Abad, C Grávalos, A Font, et al.Investigational New Drugs|January 1, 1996
Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphomaJ Rizzo, A M Levine, G R Weiss, et al.Investigational New Drugs|March 1, 2006
Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypesWilliam C Zamboni, Ramesh K Ramanathan, Howard L McLeod, et al.Pageof 372